Nixing the cells that nix immune response against cancer
A University of Colorado Cancer Center study characterizes the uptick of myeloid-derived suppressor cells in human cancer patients' spleens, revealing their immunosuppressive function. Higher splenocyte counts were associated with increased risk of death and decreased overall survival.
SourceUniversity of Colorado Anschutz Medical Campus·JournalCancer Immunology Immunotherapy·DateFeb 2, 2017